Valsts: Austrālija
Valoda: angļu
Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)
Montelukast sodium
Apotex Pty Ltd
Medicine Registered
TERRY WHITE CHEMISTS MONTELUKAST _Contains the active ingredient montelukast (as montelukast sodium)_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET READ THIS LEAFLET CAREFULLY BEFORE TAKING YOUR MEDICINE. This leaflet answers some common questions about montelukast. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. The information in this leaflet was last updated on the date listed on the last page. More recent information on this medicine may be available. ASK YOUR DOCTOR OR PHARMACIST: • if there is anything you do not understand in this leaflet, • if you are worried about taking your medicine, or • to obtain the most up-to-date information. All medicines have risks and benefits. Your doctor has weighed the risks of you using this medicine against the benefits they expect it will have for you. Pharmaceutical companies cannot give you medical advice or an individual diagnosis. Keep this leaflet with your medicine. You may need to read it again. WHAT THIS MEDICINE IS USED FOR The name of your medicine is Terry White Chemists Montelukast. It contains the active ingredient montelukast (as montelukast sodium). It is used to: • prevent asthma symptoms, including those that occur during the day and at night-time • prevent the narrowing of airways triggered by exercise • seasonal allergic rhinitis (hay fever) symptoms Montelukast tablets are not used to treat an acute attack of asthma. If an acute attack occurs, follow your doctor's instructions for your reliever medicine, and keep taking your montelukast tablets each night or as prescribed. As a preventive medicine for asthma, montelukast can be used alone or in combination with other preventive medicines, such as inhaled corticosteroids. Your doctor may reduce your dose of inhaled corticosteroid while you are taking montelukast. Asthma is a lung disease and has the following characteristics: • narrowed airways causing breathing to become difficult • inflame Izlasiet visu dokumentu
Product Information – Australia Terry White Chemists MONTELUKAST TABLET Page 1 TERRY WHITE CHEMISTS MONTELUKAST TABLET NAME OF THE MEDICINE Montelukast sodium. Chemical Name: [R-(E)]-1-[[[1-[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1- methylethyl)phenyl]propyl]thio]methyl] cyclopropane acetic acid, monosodium salt. Structural Formula: Molecular Formula: C 35 H 35 ClNNaO 3 S Molecular Weight: 608.18 CAS Registry Number: 151767-02-1 DESCRIPTION Montelukast sodium is a hygroscopic, optically active, white to off-white, free-flowing powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile. Montelukast is the optically active R stereoisomer. Each 10-mg film-coated tablet contains 10.4 mg montelukast sodium, which is equivalent to 10.0 mg of montelukast, the free acid. In addition, each 10 mg tablet contains the following inactive ingredients: Lactose Anhydrous, Cellulose Microcrystalline, Croscarmellose Sodium, Silica Colloidal Anhydrous, Magnesium Stearate, Hypromellose, Hydroxypropylcellulose, Yellow Iron Oxide, Red Iron Oxide and Titanium Dioxide. Each 5 mg chewable tablet contains montelukast sodium equivalent to 5.0 mg of montelukast, the free acid. Each 4 mg chewable tablet contains montelukast sodium equivalent to 4.0 mg of montelukast, the free acid. In addition, each 4 mg and 5 mg chewable tablet contains the following inactive ingredients: Mannitol, Cellulose Microcrystalline, Croscarmellose Sodium, Aspartame, Magnesium Stearate, Cherry 501027 AP0551 and Red Iron Oxide. PHARMACOLOGY PHARMACOKINETICS Absorption Montelukast is rapidly and nearly completely absorbed following oral administratio Izlasiet visu dokumentu